Evidence map›Paper›PMID 41447663›Full record

ArticleEuropean journal of breast health2025

Detection of the Superior Perforator with Doppler Ultrasonography in Superomedial Pedicle Reduction Mammaplasty: A Retrospective Evaluation of Vascular Safety.

Mert Ersan, Hilal Aybüke Yıldız

Abstract read
In one paragraph

Article in European journal of breast health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mert ErsanDepartment of Plastic, Reconstructive and Aesthetic Surgery, Yeditepe University Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0001-6109-8919
Hilal Aybüke YıldızDepartment of Plastic, Reconstructive and Aesthetic Surgery, Yeditepe University Faculty of Medicine, İstanbul, Türkiye.ORCID 0009-0002-9120-5003

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The superomedial pedicle technique combines aesthetic advantages with reliable vascularity in reduction mammaplasty. This study evaluated the safety and clinical outcomes of Doppler ultrasonography-guided identification of the superior perforator in the superomedial pedicle design. Materials and Methods: This retrospective study included 22 female patients who underwent bilateral superomedial pedicle reduction mammaplasty between April 2023 and April 2025. In all patients, the superior perforator was detected preoperatively using a portable handheld Doppler ultrasonography device and was incorporated into the pedicle design. All patients underwent surgery via an inverted-T pattern with the superomedial pedicle. The mean follow-up period was 1.2 years. Results: The superior perforator was identified in all patients (mean time: 3.0±0.4 minutes). No partial or total necrosis of the nipple-areola complex was observed in any patient. Wound dehiscence occurred at the T-incision site in four patients, transient areolar hypoesthesia was observed in three patients, and hypertrophic scarring developed in one patient. Aesthetic outcomes were evaluated in all patients by physical examination and standardized photography. Conclusion: Detection of the superior perforator with Doppler ultrasonography enables individualized planning of the superomedial pedicle and enhances vascular safety. This approach provides a feasible, individualized, and reliable surgical technique for reduction mammaplasty, thereby reducing complication rates.

Indexed as

Doppler ultrasonographymammaplastyperforator flapsurgical flapstreatment outcome

Identifiers

PMID41447663
PMCPMC12740289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.